Monday, May 6, 2019

US health regulator wants action against Strides Pharma's Puducherry unit

USFDA has classified the facility as OAI based on the inspection conducted from January 28 to February 5, 2019

from Latest News http://bit.ly/2J0mJeh
https://ift.tt/eA8V8J http://bit.ly/2SdCH5P

Related Posts:

0 comments: